Gene Deaf1 may play a role in type 1 diabetes
by Poonam Singhal

Stanford University's researchers have identified a gene that may play a role in the development of type 1 diabetes, an autoimmune disease in which the immune system attacks the body's insulin-producing cells.
Insulin, a hormone produced by cells of the pancreas, helps the body to absorb sugars found in food and to maintain blood sugar at appropriate levels.
The study team, led by C. Garrison Fathman, M.D., examined genes from mice that develop a type 1 diabetes-like disease. Dr. Fathman is a grantee of the National Institute of Allergy and Infectious Diseases and the National Institute of Diabetes and Digestive and Kidney Diseases, both components of the National Institutes of Health. Additional funding for the study was provided by the Special Statutory Funding Program for Type 1 Diabetes Research, a special appropriation for research on the prevention and cure for type 1 diabetes.
The investigators found that cells in the pancreatic lymph nodes of mice make two forms of the same gene called deformed epidermal autoregulatory factor 1 (Deaf1). One form is full-length and functional and the other is a shorter, nonfunctional variant form. The full-length, functional form of Deaf1 controls the production of molecules needed to eliminate immune cells that can destroy insulin-producing cells. The presence of the Deaf1 variant was found to prevent the full-length Deaf1 protein from functioning normally. Further experiments showed that the variant form blocked the genes needed to produce certain molecules involved in immune regulation.
When the researchers measured the levels of these two forms in people with type 1 diabetes and in healthy individuals, levels of the variant form were found to be higher in people with type 1 diabetes compared with those in healthy controls. In addition, the variant form, as in mice, inhibited the full-length form from functioning normally.
The researchers propose that the development of type 1 diabetes may in part be due to increased levels of the Deaf1 variant protein in pancreatic lymph nodes of people with this disease. Increased levels of Deaf1 variant may, in turn, lead to reduced production of molecules that are required to educate the immune system not to attack the body's own cells, including the insulin-producing cells of the pancreas. These results show that Deaf1 variant form is a risk factor for type 1 diabetes and provide a target for drug development to combat the disease.
(Poonam Singhal -- sub-editor compiled and published
Gene Deaf1 may play a role in type 1 diabetes at HealthNewsTrack on August 10, 2009 sourced from National Institute of Allergy and Infectious Diseases - http://www.niaid.nih.gov/)
Diabetes - recent articles and current news stories:
-
Gestational diabetes and poverty increased ADHD risk in offspring-
Low calorie diet improves heart function in diabetic obese patients-
Neural stem cell transplant may cure diabetes-
Diabetes increases risk of dementia and Alzheimer's disease-
Red meat increases type 2 diabetes riskDiabetes article/news source:
Read more health articles from
National Institute of Allergy and Infectious Diseases and
health articles from USA.
Diabetes - search related terms:
Autoimmune disease,
Blood sugar,
Deaf1,
Diabetes,
Diabetes mellitus,
Gene,
Hormone,
Immune system,
Insulin,
Pancreas,
Type 1 diabetes,
Diabetes books,
Searched keywords: diabetes (33), type 1 diabetes (6),
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.
Subscribe to Health News by Email
Current news
Found: A gene that may play a role in type 1 diabetes
About DiabetesDiabetes mellitus is a condition in which the pancreas no longer produces enough insulin or when cells stop responding to the insulin that is produced, so that glucose in the blood cannot be absorbed into the cells of the body. Symptoms include frequent urination, lethargy, excessive thirst, and hunger. The treatment includes changes in diet, oral medications, and in some cases, daily injections of insulin.